Association between neontal morbidity, gestational age and developmental delays in moderate to late preterm children
PDF (Español (España))

Keywords

Psychomotor Development
Moderate Preterm
Late Preterm
Hypoglycaemia
Neonatal Morbidity
Gestational Age
Neonatology
Neurology
Preterm Infants
Child Development

How to Cite

1.
Schonhaut L, Pérez M, Muñoz S. Association between neontal morbidity, gestational age and developmental delays in moderate to late preterm children. Andes pediatr [Internet]. 2015 Dec. 6 [cited 2025 Sep. 30];86(6):415-2. Available from: https://andespediatrica.cl/index.php/rchped/article/view/3265

Abstract

Introduction: There is evidence that children born moderate-to-late preterm (MLP) have a higher risk of hospitalisation, neonatal morbidity, and developmental delay (DD).

Objective: To determine the association between DD, gestational age, and neonatal morbidity in MLP children.

Patients and Method: A case control study design nested in a cohort of MLP children born between 2006 and 2009 at a private hospital located in the Metropolitan area of Santiago. The children were assessed with the Bayley-III Scales of Infant Development at 8 or 18 months corrected age, or at 30 months of chronological age. Neonatal records were retrospectively reviewed. A multivariate analysis was performed to determine the effect of neonatal morbidity on development.

Results: A total of 130 MLP children, 25 cases and 105 controls, were studied. Most of them (83.8%) were hospitalised during the neonatal period. Significant differences between cases and controls regarding maternal age and symptomatic hypoglycaemia were observed (crude OR 3.5, adjusted OR 8.18). It was concluded that the variables that negatively affect the rate of development are male gender, being a twin, and gestational age.

Conclusions: Symptomatic hypoglycaemia is the main risk factor for DD, while being a twin, male gender, and gestational age influenced the total development rate obtained. It is essential to develop strategies for prevention, screening, and early management of this metabolic disorder to prevent future DD.

PDF (Español (España))

Los contenidos publicados en esta revista están protegidos bajo una Licencia Creative Commons Atribución 4.0 Internacional (CC BY 4.0). Esto significa que cualquier persona es libre de compartir,  usar y construir a partir de este artículo, incluso con fines comerciales, siempre que se otorgue el crédito apropiado al autor original, se proporcione un enlace a la licencia, se indique el nombre y edición de la Revista.

Esta licencia no impone restricciones adicionales, lo que garantiza la libre circulación y reutilización del conocimiento con respeto y transparencia hacia los derechos de los autores.  (Véase El efecto del acceso abierto).